DURECT Study Site 0002 — Chicago, Illinois

DURECT Study Site 0002 is a clinical research site located in Chicago, Illinois, United States 60611.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

DURECT Study Site 0002 has participated in 1 clinical trials.

Therapeutic areas: Alcoholic Hepatitis.

Sponsors: Durect.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for DURECT Study Site 0002?

DURECT Study Site 0002 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has DURECT Study Site 0002 conducted?

DURECT Study Site 0002 has 1 clinical trials on record. Their work covers Alcoholic Hepatitis.

Is DURECT Study Site 0002 accredited by Crixeo Health?

DURECT Study Site 0002 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about DURECT Study Site 0002?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.